• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Salarius Pharmaceuticals Inc (NQ: SLRX )

    1.490 -0.060 (-3.87%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 40,329
    Open 1.580
    Bid (Size) 1.460 (5)
    Ask (Size) 1.600 (68)
    Prev. Close 1.550
    Today's Range 1.490 - 1.650
    52wk Range 1.350 - 7.600
    Shares Outstanding 44,778,794
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q2 2024
    SLRX stock results show that Salarius Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    (SLRX) - Analyzing Salarius Pharmaceuticals's Short Interest
    Via Benzinga

    Performance

    YTD
    -70.90%
    -70.90%
    1 Month
    -36.86%
    -36.86%
    3 Month
    -54.68%
    -54.68%
    6 Month
    -72.59%
    -72.59%
    1 Year
    -78.59%
    -78.59%

    More News

    Read More
    Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Dow Jumps 200 Points; Honeywell Trims Profit Outlook
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Why Is Salarius Pharmaceuticals (SLRX) Stock Up 90% Today?
    Via InvestorPlace
    Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
    Via Benzinga
    SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q4 2023
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.